Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Melphalan price, strengths & recalls

Melphalan has no weekly pharmacy acquisition cost. 13 manufacturers make it. It is in shortage (being discontinued). It has 1 recall on record, none ongoing. Its official label last changed on January 9, 2026.

Being discontinuedGeneric
No weekly pricePharmacy acquisition costs aren't published for this drug - usually because it's given in clinics or hospitals.

Melphalan price by strength

What pharmacies pay for each strength and form this week, for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
50 mg injectionNot priced this week

Supply status: shortages & recalls

In shortage1 product is short or being discontinued
No ongoing recalls1 recall on record, latest Apr 29, 2015

Shortages

  • Melphalan Hydrochloride, Injection, Kit (NDC 63323-760-20)Fresenius Kabi USA, LLC · Being discontinued Sep 16, 2026 · Updated Sep 16, 2026Discontinuation of the manufacture of the drug

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for melphalan? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJanuary 9, 2026
Version2 of 2
EffectiveJan 8, 2026
Read the label

Melphalan Hydrochloride for Injection (For Intravenous Infusion)

This drug has a boxed warning

WARNING

Melphalan should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. Severe bone marrow suppression with resulting infection or bleeding may occur. Controlled trials comparing intravenous (IV) to oral melphalan have shown more myelosuppression with the IV formulation. Hypersensitivity reactions, including anaphylaxis, have occurred in approximately 2% of patients who received the IV formulation. Melphalan is leukemogenic in humans. Melphalan produces chromosomal aberrations

in vitroand

in vivo and, therefore, should be considered potentially mutagenic in humans.

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
9 approved generic applications on the market

Melphalan questions

Is melphalan in shortage?

Yes. 1 product is listed as in shortage or being discontinued (being discontinued). See which ones.

Has melphalan been recalled?

1 recall on record, none ongoing. Recalls name specific lots - check yours.

When did the melphalan label last change?

The official label was last updated on January 9, 2026 (version 2). See what changed.

Talk about melphalan

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.